The Infinion Biopharma Ltd Date Will Be Updated Soon .
Infinion Biopharma Ltd is a pharmaceutical licensing and commercialization company specializing in high-value, novel pharmaceuticals in various therapeutic areas. The company has filed an IPO prospectus to raise an undisclosed amount by selling 45 lakh equity shares.
Start your investing journey today. How do you open your own demat account for free?
Bidding Dates
Coming Soon
Price Range
₹0 per share
Face Value
₹0 per share
GMP
₹0
Infinion Biopharma Ltd GMP
The Infinion Biopharma Ltd IPO GMP is ₹[].
IPO Overview
Infinion Biopharma has filed preliminary papers with Sebi to raise funds through an initial share sale. The initial public offering (IPO) comprises the sale of 45 lakh equity shares at a face value of Rs. 10 per share. The company may consider a pre-IPO placement of up to 7 lakh equity shares.
They have developed significant business relationships with several USA and UK pharmaceutical companies for research, design, and development of a vast range of therapeutic products.
Infinion Biopharma Ltd IPO Financials
| Particulars | FY21 | FY20 | FY19 |
| Total Income | 68,987.06 | NA | NA |
| EBITDA | NA | NA | NA |
| EBITDA Margin (%) | NA | NA | NA |
| Profit After Tax | 64,240.27 | 13,697.46 | 3,635.15 |
| EPS | 6.24 | 1.71 | 0.66 |
| ROE | NA | NA | NA |
Company Profile
Infinion Biopharma engages in pharmaceutical licensing and commercialising high-value, innovative products in various therapeutic areas. The company has filed an IPO prospectus to sell 45 lakh equity shares to raise an undisclosed amount. Infinion Biopharma is a research-driven life science company that licenses and commercialises various therapeutic drugs. They are involved in developing technology combining biophysics and engineering with traditional pharmacology and biochemistry to produce high-value, innovative products. It has created a global scientific ecosystem with multiple disciplines, including biophysics, biochemistry, pharmacology and biotechnology, to create innovative products to manage and treat various diseases.
Infinion Biopharma is an innovation-driven life sciences company that combines biophysics and engineering with traditional pharmacology and biochemistry to produce high-value, innovative products across various therapeutic areas.
IPO Strenghts
- Experienced promoters and a competent management team.
- Well-established relationships with a loyal customer base.
- Access to markets worldwide, enabling global reach.
IPO Weakness
- Heavy reliance on customers based in the United States.
- Need to adhere to multiple laws and regulations in these countries to ensure compliance.
- Competition from other players in the market.
